Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein

Supplemental Digital Content is available in the text. Objective: ApoM enriches S1P (sphingosine-1-phosphate) within HDL (high-density lipoproteins) and facilitates the activation of the S1P1 (S1P receptor type 1) by S1P, thereby preserving endothelial barrier function. Many protective functions exerted by HDL in extravascular tissues raise the question of how S1P regulates transendothelial HDL transport. Approach and Results: HDL were isolated from plasma of wild-type mice, Apom knockout mice, human apoM transgenic mice or humans and radioiodinated to trace its binding, association, and transport by bovine or human aortic endothelial cells. We also compared the transport of fluorescently-labeled HDL or Evans Blue, which labels albumin, from the tail vein into the peritoneal cavity of apoE-haploinsufficient mice with (apoE-haploinsufficient mice with endothelium-specific knockin of S1P1) or without (control mice, ie, apoE-haploinsufficient mice without endothelium-specific knockin of S1P1) endothelium-specific knockin of S1P1. The binding, association, and transport of HDL from Apom knockout mice and human apoM-depleted HDL by bovine aortic endothelial cells was significantly lower than that of HDL from wild-type mice and human apoM-containing HDL, respectively. The binding, uptake, and transport of 125I-HDL by human aortic endothelial cells was increased by an S1P1 agonist but decreased by an S1P1 inhibitor. Silencing of SR-BI (scavenger receptor BI) abrogated the stimulation of 125I-HDL transport by the S1P1 agonist. Compared with control mice, that is, apoE-haploinsufficient mice without endothelium-specific knockin of S1P1, apoE-haploinsufficient mice with endothelium-specific knockin of S1P1 showed decreased transport of Evans Blue but increased transport of HDL from blood into the peritoneal cavity and SR-BI expression in the aortal endothelium. Conclusions: ApoM and S1P1 promote transendothelial HDL transport. Their opposite effect on transendothelial transport of albumin and HDL indicates that HDL passes endothelial barriers by specific mechanisms rather than passive filtration.

[1]  A. von Eckardstein,et al.  The Endothelium Is Both a Target and a Barrier of HDL’s Protective Functions , 2021, Cells.

[2]  A. von Eckardstein,et al.  Transendothelial transport of lipoproteins. , 2020, Atherosclerosis.

[3]  A. von Eckardstein,et al.  Sphingosine-1-phosphate receptors 1 and 3 regulate the expression of scavenger receptor B1 in human aortic endothelial cells , 2020, bioRxiv.

[4]  J. Beckman,et al.  Sex as a Biological Variable in Atherosclerosis , 2020, Circulation research.

[5]  T. Hornemann,et al.  Structure-function relationships of HDL in diabetes and coronary heart disease. , 2019, JCI insight.

[6]  T. Hla,et al.  Sphingosine 1-phosphate: Lipid signaling in pathology and therapy , 2019, Science.

[7]  M. Lauritzen,et al.  Apolipoprotein M-bound sphingosine-1-phosphate regulates blood–brain barrier paracellular permeability and transcytosis , 2019, bioRxiv.

[8]  J. C. Wolters,et al.  The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance. , 2019, JCI insight.

[9]  T. Hla,et al.  Sphingosine 1-phosphate receptor 1 regulates cell-surface localization of membrane proteins in endothelial cells. , 2019, Biochimica et biophysica acta. General subjects.

[10]  T. Lüscher,et al.  Mouse Models for Atherosclerosis Research—Which Is My Line? , 2019, Front. Cardiovasc. Med..

[11]  E. Fisher,et al.  SR-B1 Drives Endothelial Cell LDL Transcytosis via DOCK4 to Promote Atherosclerosis , 2019, Nature.

[12]  S. Swendeman,et al.  Sphingosine 1‐Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex–Induced Vascular Injury , 2018, Arthritis & rheumatology.

[13]  R. Proia,et al.  Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R−/−) Mice , 2018, Thrombosis and Haemostasis.

[14]  C. Christoffersen,et al.  Apolipoprotein M mediates sphingosine-1-phosphate efflux from erythrocytes , 2017, Scientific Reports.

[15]  A. von Eckardstein,et al.  VEGF-A Regulates Cellular Localization of SR-BI as Well as Transendothelial Transport of HDL but Not LDL , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[16]  A. von Eckardstein,et al.  HDL cholesterol: reappraisal of its clinical relevance , 2017, Clinical Research in Cardiology.

[17]  H. Schunkert,et al.  Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis. , 2017, Cell metabolism.

[18]  S. Swendeman,et al.  Impaired endothelial barrier function in apolipoprotein M‐deficient mice is dependent on sphingosine‐1‐phosphate receptor 1 , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  A. von Eckardstein,et al.  Itinerary of high density lipoproteins in endothelial cells. , 2016, Biochimica et biophysica acta.

[20]  M. Cybulsky,et al.  A novel assay uncovers an unexpected role for SR-BI in LDL transcytosis. , 2015, Cardiovascular research.

[21]  R. Proia,et al.  HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation , 2015, Science Signaling.

[22]  S. Spiegel,et al.  Uncleaved ApoM Signal Peptide Is Required for Formation of Large ApoM/Sphingosine 1-Phosphate (S1P)-enriched HDL Particles* , 2015, The Journal of Biological Chemistry.

[23]  J. Poleszczuk,et al.  Can the Three Pore Model Correctly Describe Peritoneal Transport of Protein? , 2014, ASAIO journal.

[24]  T. Hornemann,et al.  Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate , 2014, Journal of Lipid Research.

[25]  S. Spiegel,et al.  Hepatic Apolipoprotein M (ApoM) Overexpression Stimulates Formation of Larger ApoM/Sphingosine 1-Phosphate-enriched Plasma High Density Lipoprotein* , 2013, The Journal of Biological Chemistry.

[26]  A. von Eckardstein,et al.  Interleukin 6 Stimulates Endothelial Binding and Transport of High-Density Lipoprotein Through Induction of Endothelial Lipase , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[27]  C. Weber,et al.  KRP-203, Sphingosine 1-Phosphate Receptor Type 1 Agonist, Ameliorates Atherosclerosis in LDL-R−/− Mice , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[28]  Kim Pin Yeo,et al.  Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL. , 2013, Cell metabolism.

[29]  C. Weber,et al.  Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice. , 2012, Vascular pharmacology.

[30]  T. Hornemann,et al.  Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism. , 2011, Atherosclerosis.

[31]  B. Dahlbäck,et al.  Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M , 2011, Proceedings of the National Academy of Sciences.

[32]  Amanda L. Brown,et al.  Apolipoprotein M expression increases the size of nascent preβ HDL formed by ATP binding cassette transporter A1 , 2010, Journal of Lipid Research.

[33]  A. von Eckardstein,et al.  High-Density Lipoprotein Transport Through Aortic Endothelial Cells Involves Scavenger Receptor BI and ATP-Binding Cassette Transporter G1 , 2009, Circulation research.

[34]  Jackelyn A. Alva,et al.  VE‐cadherin‐CreERT2 transgenic mouse: A model for inducible recombination in the endothelium , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[35]  A. von Eckardstein,et al.  ATP-Binding Cassette Transporter A1 Modulates Apolipoprotein A-I Transcytosis Through Aortic Endothelial Cells , 2006, Circulation research.

[36]  A. von Eckardstein,et al.  Binding, internalization and transport of apolipoprotein A-I by vascular endothelial cells. , 2006, Biochimica et biophysica acta.

[37]  M. N. Poy,et al.  Apolipoprotein M is required for preβ-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis , 2005, Nature Medicine.

[38]  T. Michel,et al.  VEGF induces S1P1 receptors in endothelial cells: Implications for cross-talk between sphingolipid and growth factor receptors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  B. Wieringa,et al.  Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. , 1994, Atherosclerosis.

[40]  N. Maeda,et al.  Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. , 1994, The Journal of clinical investigation.

[41]  B. Dahlbäck,et al.  High-Density Lipoprotein–Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1 , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[42]  A. von Eckardstein,et al.  High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis. , 2013, Circulation journal : official journal of the Japanese Circulation Society.